Tempus AI, Inc. (NASDAQ:TEM) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $45.56.

A number of equities analysts recently issued reports on TEM shares. TD Cowen initiated coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $50.00 target price on the stock. Loop Capital started coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price target for the company. William Blair began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set an "outperform" rating on the stock. JPMorgan Chase & Co. increased their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Finally, Longbow Research initiated coverage on Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $48.00 price objective for the company.

Tempus AI Trading Up 8.7 %

TEM traded up $4.34 during midday trading on Friday, hitting $54.43. The company had a trading volume of 1,691,898 shares, compared to its average volume of 1,236,331. The stock's 50 day simple moving average is $48.37. Tempus AI has a 52 week low of $22.89 and a 52 week high of $77.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, research analysts forecast that Tempus AI will post -6.51 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. NEA Management Company LLC purchased a new stake in Tempus AI during the 2nd quarter valued at $160,048,000. Novo Holdings A S bought a new position in shares of Tempus AI during the 2nd quarter worth approximately $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in shares of Tempus AI in the 2nd quarter worth $128,133,000. Alphabet Inc. purchased a new stake in Tempus AI in the second quarter valued at about $54,289,000. Finally, Lingotto Investment Management LLP purchased a new stake in Tempus AI in the second quarter valued at about $32,685,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.